|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.4 INR | +1.02% |
|
+4.05% | +26.60% |
Biofil Chemicals and Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 136.16 million compared to INR 16.46 million a year ago. Revenue was INR 136.49 million compared to INR 16.76 million a year ago.
Net income was INR 2.09 million compared to net loss of INR 0.285 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +26.60% | 13.21M | |
| +21.20% | 43.92B | |
| +24.56% | 23.09B | |
| +19.40% | 15.35B | |
| +13.23% | 13.61B | |
| +46.58% | 12.02B | |
| -10.14% | 7B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.07% | 5.6B |
BIOFIL CHEMICALS AND PHARMACEUTICALS LIMITED 